Health Care

Doctor Care Anywhere Group Plc (DOC)

Doctor Care Anywhere is a UK-founded digital health company providing virtual GP consultations and other telehealth services. It operates primarily on a B2B2C model, partnering with major insurers, like AXA Health, and corporate clients to offer its 24/7 platform to their members and employees. The company's core service allows patients to book and attend video or phone appointments with doctors for diagnostics, prescriptions, and specialist referrals.

Market Cap

A$59M

Shares on Issue

N/A

Company WebsiteAI coverage updated hourlyData from ASX filings

Price Chart

Loading chart…

AI Analysis

As a micro-cap telehealth provider, Doctor Care Anywhere is currently focused on growing its revenue and patient base in a competitive post-pandemic market. The company's recent performance has been characterised by modest revenue growth offset by significant cash burn, a common trait for early-stage tech companies. Its key metrics are centred on consultation volumes, eligible lives covered by its partners, and average revenue per user, rather than profitability. The share price has been under pressure, reflecting broader market sentiment against loss-making growth stocks and concerns over its path to a sustainable business model and reliance on its major partner, AXA Health.

The company's forward-looking strategy centres on three pillars: expanding its channel partnerships beyond AXA to diversify revenue, broadening its service offerings into higher-margin areas like mental health and specialist care, and improving operational efficiency through technology. Upcoming catalysts will likely be the announcement of new B2B contracts or positive quarterly cash flow reports (Appendix 4C) that demonstrate progress in managing costs and growing revenue. The long-term outlook depends on its ability to scale operations profitably and differentiate its service in the crowded UK digital health landscape.

Bull Case

  • Significant growth potential through securing new major B2B channel partners, which would rapidly expand its addressable market and diversify revenue streams.
  • Structural tailwinds from the increasing adoption of telehealth by patients and healthcare systems seeking convenience and efficiency.
  • Opportunity to increase average revenue per user by successfully cross-selling new, higher-margin services such as mental health support and specialist consultations.

Bear Case

  • High concentration risk with a significant majority of revenue historically derived from its partnership with AXA Health.
  • Intense competition from other well-funded telehealth providers in the UK, leading to pricing pressure and high customer acquisition costs.
  • Consistent cash burn and a history of unprofitability may necessitate further dilutive capital raisings to fund operations until it reaches scale.

Recent Announcements

Quarterly Activities/Appendix 4C Cash Flow Report

🚨 Price Sensitive
28 Jan 2026Quarterly Report

The ASX announcement for Ticker: DOC reveals that the Commitments Test Entity has provided a detailed quarterly cash flow report, which investors can review in Appendix 4C of their latest Quarterly Reports.

Quarterly Activity Report Release Date Announcement

23 Jan 2026Quarterly Report

Change of Director's Interest Notice - John Stier

14 Jan 2026Director Dealing

FAQs

What does DOC do?

Doctor Care Anywhere is a UK-based telehealth company providing virtual GP consultations via its digital platform. It primarily partners with insurance companies and corporate clients to offer medical services to their members and employees.

Is DOC a good investment?

DOC is a speculative, high-risk investment. The potential upside lies in the growing telehealth market and its ability to sign new large-scale partners. However, investors should be aware of its current unprofitability, intense competition, and reliance on key clients.

What drives DOC's share price?

Key drivers include quarterly reports on user and revenue growth, announcements of new major B2B partnerships, and its progress towards managing cash burn and achieving profitability. Broader market sentiment towards speculative, high-growth technology stocks also heavily influences its valuation.